These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 13554856)

  • 21. Biology of plasma cells.
    Chen-Kiang S
    Best Pract Res Clin Haematol; 2005; 18(4):493-507. PubMed ID: 16026733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Stratigraphy of the occipital foramen and of the sub-occipital portion of the spine].
    OLIVA L
    Minerva Otorinolaringol; 1954; 4(4):175-88. PubMed ID: 13213805
    [No Abstract]   [Full Text] [Related]  

  • 23. Multiple myeloma: primary bone tumor with systemic manifestations.
    Bilsky MH; Azeem S
    Neurosurg Clin N Am; 2008 Jan; 19(1):31-40. PubMed ID: 18156045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The absence of CD56 on malignant plasma cells in the cerebrospinal fluid is the hallmark of multiple myeloma involving central nervous system.
    Chang H; Bartlett ES; Patterson B; Chen CI; Yi QL
    Br J Haematol; 2005 May; 129(4):539-41. PubMed ID: 15877737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bone lesion in multiple myeloma--bone mineral density measured by dual energy X-ray absorptiometry in multiple myeloma].
    Takata M; Umeda M
    Rinsho Ketsueki; 1997 Apr; 38(4):289-91. PubMed ID: 9146053
    [No Abstract]   [Full Text] [Related]  

  • 26. Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma.
    Caligaris-Cappio F; Bergui L; Tesio L; Pizzolo G; Malavasi F; Chilosi M; Campana D; van Camp B; Janossy G
    J Clin Invest; 1985 Sep; 76(3):1243-51. PubMed ID: 2931452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Myeloma precursor cells and their differentiation].
    Kawano MM
    Nihon Rinsho; 1995 Mar; 53(3):552-6. PubMed ID: 7699884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solitary sclerosing plasma-cell myeloma of the spine. Case report.
    Roberts M; Rinaudo PA; Vilinskas J; Owens G
    J Neurosurg; 1974 Jan; 40(1):125-9. PubMed ID: 4808479
    [No Abstract]   [Full Text] [Related]  

  • 29. [The value of radiology in the diagnosis of myelomas].
    BERNAILLE C; VALLEE G; MICHEL JR
    Fr Med; 1961 Nov; 24():521-9. PubMed ID: 13867993
    [No Abstract]   [Full Text] [Related]  

  • 30. MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes.
    Girlanda S; Fortis C; Belloni D; Ferrero E; Ticozzi P; Sciorati C; Tresoldi M; Vicari A; Spies T; Groh V; Caligaris-Cappio F; Ferrarini M
    Cancer Res; 2005 Aug; 65(16):7502-8. PubMed ID: 16103105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The plasma cell in radiology.
    Pear BL
    Am J Roentgenol Radium Ther Nucl Med; 1968 Apr; 102(4):908-15. PubMed ID: 4966855
    [No Abstract]   [Full Text] [Related]  

  • 32. [Neurologic sequelae of bone changes in multiple myeloma and its therapy].
    Basić-kes V; Basić-Jukić N; Kes P; Demarin V; Labar B
    Acta Med Croatica; 2002; 56(3):103-7. PubMed ID: 12630341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Initial clinical manifestations of multiple myeloma].
    LEBON J; MESSERSCHMITT J; AMOUYAL J
    Presse Med (1893); 1956 Mar; 64(25):587-8. PubMed ID: 13335839
    [No Abstract]   [Full Text] [Related]  

  • 34. Bone marrow plasma cell infiltration in multiple myeloma.
    de Gramont A; Benitez O; Smadja N; Brissaud P; Sirinelli A; Hubert D; Krulik M; Debray J
    Br J Haematol; 1984 Jun; 57(2):351-3. PubMed ID: 6733051
    [No Abstract]   [Full Text] [Related]  

  • 35. Auer rod-like inclusions in myeloma cells in a patient with IgG multiple myeloma.
    Das S; Kakkar N; Ahuja B; Lal M
    Indian J Pathol Microbiol; 2006 Oct; 49(4):561-3. PubMed ID: 17183855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognostic value of the ratio of bone marrow plasma cells in multiple myeloma].
    Pasqualetti P; Colantonio D; Casale R
    Minerva Med; 1990 Mar; 81(3):129-33. PubMed ID: 2320280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of multiple myeloma associated with phagocytic plasma cells and a variety of abnormal morphological features of bone marrow cells].
    Hishitani Y; Kanoh T; Murao H; Kakehi K; Mozai T
    Rinsho Ketsueki; 1986 Oct; 27(10):1886-90. PubMed ID: 3820612
    [No Abstract]   [Full Text] [Related]  

  • 38. Mast cells influence the proliferation rate of myeloma plasma cells.
    Pappa CA; Tsirakis G; Stavroulaki E; Kokonozaki M; Xekalou A; Konsolas I; Alexandrakis MG
    Cancer Invest; 2015 Apr; 33(4):137-41. PubMed ID: 25738408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells.
    Kim D; Park CY; Medeiros BC; Weissman IL
    Leukemia; 2012 Dec; 26(12):2530-7. PubMed ID: 22733078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sclerostin is overexpressed by plasma cells from multiple myeloma patients.
    Brunetti G; Oranger A; Mori G; Specchia G; Rinaldi E; Curci P; Zallone A; Rizzi R; Grano M; Colucci S
    Ann N Y Acad Sci; 2011 Nov; 1237():19-23. PubMed ID: 22082361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.